Published in PLoS One on January 10, 2017
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37
Helicobacter pylori infection and the development of gastric cancer. N Engl J Med (2001) 17.13
Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer (2011) 16.97
A model for gastric cancer epidemiology. Lancet (1975) 4.02
Accuracy of GastroPanel for the diagnosis of atrophic gastritis. Eur J Gastroenterol Hepatol (2014) 2.49
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2013. Cancer Res Treat (2016) 2.31
Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol (2003) 2.23
Seroprevalence of Helicobacter pylori in South Korea. Helicobacter (2007) 2.21
Low plasma ghrelin levels in patients with Helicobacter pylori-associated gastritis. Am J Med (2004) 1.91
Gastritis staging in clinical practice: the OLGA staging system. Gut (2006) 1.90
Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer (2006) 1.71
The gastric precancerous cascade. J Dig Dis (2012) 1.70
The management of gastric polyps. Gut (2010) 1.65
Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen (2004) 1.60
The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc (2010) 1.46
Staging gastritis: an international proposal. Gastroenterology (2005) 1.29
Gastric dysplasia. A histological follow-up study. Am J Surg Pathol (1987) 1.28
Risk of high-grade dysplasia or carcinoma in gastric biopsy-proven low-grade dysplasia: an analysis using the Vienna classification. Endoscopy (2011) 1.24
Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol (2007) 1.22
Risk factors suggesting malignant transformation of gastric adenoma: univariate and multivariate analysis. Endoscopy (2001) 1.20
Gastric dysplasia. A follow-up study. Am J Gastroenterol (1993) 1.19
Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group. Scand J Gastroenterol (2000) 1.19
Gastric atrophy, metaplasia, and dysplasia: a clinical perspective. J Clin Gastroenterol (2003) 1.16
Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther (2010) 1.15
Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol (2008) 1.14
Discrepancy between endoscopic forceps biopsy and endoscopic resection in gastric epithelial neoplasia. Surg Endosc (2013) 1.12
Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population. Dig Endosc (2009) 1.10
Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms. Am J Gastroenterol (2010) 1.08
Is endoscopic forceps biopsy enough for a definitive diagnosis of gastric epithelial neoplasia? J Gastroenterol Hepatol (2010) 1.07
Gastric dysplasia: a ten-year follow-up study. Pathol Res Pract (1994) 1.05
Features of gastritis predisposing to gastric adenoma and early gastric cancer. J Clin Pathol (2002) 1.04
Histological risk markers for non-cardia early gastric cancer. Pattern of mucin expression and gastric cancer. Virchows Arch (2006) 1.03
Circulating acylated ghrelin level decreases in accordance with the extent of atrophic gastritis. J Gastroenterol (2009) 0.99
Diagnostic group classifications of gastric neoplasms by endoscopic resection criteria before and after treatment: real-world experience. Surg Endosc (2015) 0.97
The risk factors for discrepancy after endoscopic submucosal dissection of gastric category 3 lesion (low grade dysplasia). Dig Dis Sci (2013) 0.94
Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies. J Clin Endocrinol Metab (2007) 0.94
OLGA and OLGIM stage distribution according to age and Helicobacter pylori status in the Korean population. Helicobacter (2014) 0.84
Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea. Gut Liver (2013) 0.83
Incidence of gastric cancer after endoscopic resection of gastric adenoma. Gastrointest Endosc (2015) 0.82
Secondary prevention of epidemic gastric cancer in the model of Helicobacter pylori-associated gastritis. Dig Dis (2014) 0.81
Value of gastrin-17 in detecting antral atrophy. Adv Med Sci (2011) 0.80
Staging of intestinal- and diffuse-type gastric cancers with the OLGA and OLGIM staging systems. Aliment Pharmacol Ther (2013) 0.79
Decrease of serum total ghrelin in extensive atrophic gastritis: comparison with pepsinogens in histological reference. Scand J Gastroenterol (2016) 0.78
Features of Gastric Carcinoma With Lymphoid Stroma Associated With Epstein-Barr Virus. Clin Gastroenterol Hepatol (2015) 1.47